Trademark Search  /  REQUINATE

REQUINATE

○ Dead · Cancelled

U.S. federal trademark · Serial No. 78262195 · Reg. No. 2326837

Mark
REQUINATE
Status
Cancelled
Serial Number
78262195
Registration No.
2326837
Filing Date
March 17, 2003
Registration Date
November 14, 2003
Class(es)
Class 001, Class 005, Class 010, Class 042

Owners

Oxford BioMedica plc
11 · Oxford, GB
Oxford BioMedica plc
11 · Oxford, GB
Oxford BioMedica plc
11 · Oxford, GB

Goods & Services

Chemical and biochemical products for use in gene delivery technology, namely, enzymes, proteins, growth factors and chemicals for in-vitro use in laboratories and for analysis in gene delivery technology; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid variations thereof, all for in-vivo use in gene delivery technology

Gene therapy and prophylaxis products, namely, gene delivery, gene transfer, gene regulation and gene modulation for the treatment of hemophilia, blood disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, vascular disorders, disorders arising from improper vascularization and single gene disorders; pharmaceutical substances and preparations namely, vaccines, genetically engineered proteins enzymes and enzyme preparations for medical diagnostic use; retroviral vector and retroviral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for the treatment of single gene disorders

Scientific and medical research and development; engineering services; biotechnology services, namely, research for others in the field of biotechnology, biotechnology research in the development of therapeutic and prophylactic products and vaccines; licensing of intellectual property; advisory services relating to the research and development of gene therapy and prophylaxis products; consultation services in the field of medical and scientific research in the field of professional gene therapy; medical research and development in the field of vector production technologies

Instruments and apparatus for the administration of antibody-based therapy and prophylaxis preparations and substances, namely, pre-filled vials, syringes and injectors for medical purposes, all for the treatment of single gene disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, blood disorders, vascular disorders and disorders arising from inappropriate vascularization

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "REQUINATE" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.